Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review.
J Redgrave, D Day, H Leung...
https://pubmed.ncbi.nlm.nih.gov/30217648/Actively Recruiting
Led by Universitas Diponegoro · Updated on 2025-07-10
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the effects of low-level tragus stimulation LLTS on heart function in patients who have experienced ST-segment Elevation Myocardial Infarction STEMI and are undergoing primary percutaneous coronary intervention PPCI. This study aims to understand if LLTS can improve measures such as left ventricular ejection fraction, wall motion score index, and diastolic function compared to a sham control. The safety of LLTS in this setting is also being assessed. Participants will be randomly assigned to one of two groups the treatment group receiving LLTS via the Parasym device on the left tragus for 60 minutes, or the sham control group where the Parasym device is implanted without active stimulation for the same duration. Both groups will undergo transthoracic echocardiography examinations before and after PPCI to assess heart function. During the study, participants will have echocardiographic measurements taken before PPCI, one day after PPCI, and 30 days after PPCI to monitor changes in left ventricular ejection fraction, wall motion score index, and diastolic function. The study will last through these time points to evaluate both the effect and safety of LLTS treatment in STEMI patients.
CONDITIONS
The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial
L
Leo Deddy Pradipta
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universitas Diponegoro
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Up to 12 hours before enrollment
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for eligibility assessment
Duration - 1 day
Participants undergo low-level tragus stimulation or sham implantation using the Parasym Neuromodulation Device for 60 minutes.
1 visit (in-person) for device application
Duration - 30 days
Participants have echocardiographic assessments before, 1 day after, and 30 days after primary percutaneous coronary intervention (PPCI) to evaluate heart function.
3 visits (in-person) including baseline, 1 day post-PPCI, and 30 days post-PPCI
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
J Redgrave, D Day, H Leung...
https://pubmed.ncbi.nlm.nih.gov/30217648/Lilei Yu, Bing Huang, Sunny S Po...
https://pubmed.ncbi.nlm.nih.gov/28797427/Universitas Diponegoro
Lead Sponsor